Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003574
What this trial is testing

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00157703
What this trial is testing

G207 Followed by Radiation Therapy in Malignant Glioma

Who this might be right for
Malignant Glioma
MediGene 9
Early research (Phase 1)Study completedNCT00004028
What this trial is testing

Carmustine in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Early research (Phase 1)Study completedNCT00031083
What this trial is testing

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more
Biogen 12
Testing effectiveness (Phase 2)Study completedNCT00720356
What this trial is testing

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 115
Testing effectiveness (Phase 2)Study completedNCT00124657
What this trial is testing

Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT04977375
What this trial is testing

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Chirag G. Patil 10
Early research (Phase 1)Looking for participantsNCT07179328
What this trial is testing

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Who this might be right for
GBMGlioblastoma Multiforme (GBM)Glioblastoma Multiforme of Brain+5 more
Sunnybrook Health Sciences Centre 10
Early research (Phase 1)Study completedNCT02457845
What this trial is testing

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Who this might be right for
Supratentorial Neoplasms, MalignantMalignant GliomaGlioblastoma+4 more
Gregory K. Friedman, MD 13
Large-scale testing (Phase 3)Study completedNCT00482677
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Canadian Cancer Trials Group 562
Testing effectiveness (Phase 2)Looking for participantsNCT03213002
What this trial is testing

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more
Northwell Health 67
Testing effectiveness (Phase 2)Study completedNCT01120639
What this trial is testing

Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform

Who this might be right for
GlioblastomaCancer of Brain and Nervous SystemGlioblastoma Multiforme
Stanford University 30
Testing effectiveness (Phase 2)Ended earlyNCT03330197
What this trial is testing

Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG

Who this might be right for
Pediatric Brain TumorDiffuse Intrinsic Pontine Glioma
Alaunos Therapeutics 6
Not applicableStudy completedNCT07673679
What this trial is testing

GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4

Who this might be right for
GliomaGlioma (Diagnosis)Astrocytoma+2 more
Deep Learning Institute of Radiological Sciences 1,372
Not applicableStudy completedNCT05039346
What this trial is testing

Quality of Life and Patient Needs in Advanced High Grade Gliomas

Who this might be right for
Quality of LifeBrain TumorGlioblastoma+2 more
Henry Ford Health System 55
Early research (Phase 1)Active Not RecruitingNCT04978727
What this trial is testing

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
MedulloblastomaGlioblastoma MultiformeAnaplastic Astrocytoma+5 more
Children's Oncology Group 35
Early research (Phase 1)Study completedNCT01171469
What this trial is testing

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Who this might be right for
Brain TumorGlioblastomaMedulloblastoma+2 more
Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)Study completedNCT00335764
What this trial is testing

Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 92
Early research (Phase 1)Study completedNCT00762255
What this trial is testing

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute 19
Next Page